Publications by authors named "Shingo Nasu"

Claim this Profile
E
Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients.
Tomonori Hirashima, Yoshimi Noda, Hidekazu Suzuki, Shingo Nasu, Ayako Tanaka

Anticancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transbronchial Cryobiopsy for Miliary Tuberculosis Mimicking Hypersensitivity Pneumonitis.
Shingo Nasu, Kunimitsu Kawahara, Yuki Han, Norio Okamoto, Yoshitaka Tamura

Intern Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of afatinib for the treatment of non-small-cell lung cancer following osimertinib-induced interstitial lung disease: A retrospective study.
Shingo Nasu, Hidekazu Suzuki, Takayuki Shiroyama, Ayako Tanaka, Yumiko Samejima

Invest New Drugs· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Pre-treatment Interferon-gamma Release in Patients With Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitors.
Tomonori Hirashima, Tomohiro Kanai, Hidekazu Suzuki, Hiroko Yoshida, Akane Matsusita, Shingo Nasu

Anticancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Severe Heart Failure in a Patient with Squamous Non-small-cell Lung Cancer During Nivolumab Treatment.
Yumiko Samejima, Atsuhiko Iuchi, Tomohiro Kanai, Yoshimi Noda, Shingo Nasu

Intern Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between Extracellular Water-to-Total Body Water Ratio and Therapeutic Durability for Advanced Lung Cancer.
Yoshimi Noda, Hidekazu Suzuki, Tomohiro Kanai, Yumiko Samejima, Shingo Nasu

Anticancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tree-in-bud Pattern in ALK-positive Lung Adenocarcinoma.
Takayuki Shiroyama, Shingo Nasu, Ayako Tanaka, Tomonori Hirashima

Intern Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Quantitative Interferon-gamma Levels in Non-small-cell Lung Cancer Patients' Response to Immune Checkpoint Inhibitors.
Tomohiro Kanai, Hidekazu Suzuki, Hiroko Yoshida, Akane Matsushita, Hiromi Kawasumi, Shingo Nasu

Anticancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Tomonori Hirashima, Tomohiro Kanai, Hidekazu Suzuki, Hiroko Yoshida, Akane Matsushita, Shingo Nasu

Anticancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Utilities of Cryobiopsy and Forceps Biopsy for Peripheral Lung Cancer.
Shingo Nasu, Norio Okamoto, Hidekazu Suzuki, Takayuki Shiroyama, Ayako Tanaka

Anticancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of successful concurrent anti-cancer treatment in a patient who developed follicular lymphoma during treatment with afatinib for advanced lung adenocarcinoma.
Kentaro Masuhiro, Genju Koh, So Takata, Shingo Nasu, Hiromune Takada

Respir Med Case Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-challenge chemotherapy in patients with sensitive relapse small-cell lung cancer and interstitial lung disease.
Shingo Nasu, Hidekazu Suzuki, Kazunori Moriizumi, Yuki Hara, Satoshi Tanaka

J Thorac Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents.
So Takata, Genju Koh, Yuki Han, Hiroko Yoshida, Takayuki Shiroyama, Shingo Nasu

J Infect Chemother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M Mutations.
Shingo Nasu, Takayuki Shiroyama, Satomu Morita, So Takata, Hiromune Takada

Intern Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracoscopic Images of Primary Pleural Melanoma.
Takayuki Shiroyama, Shingo Nasu, Satomu Morita, Norio Okamoto

Intern Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pleural Effusion on Outcomes of Patients Receiving Osimertinib for NSCLC Harboring T790M.
Kentaro Masuhiro, Takayuki Shiroyama, Hidekazu Suzuki, S O Takata, Shingo Nasu

Anticancer Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin Rash Can Be a Useful Marker for Afatinib Efficacy.
Shingo Nasu, Hidekazu Suzuki, Takayuki Shiroyama, Ayako Tanaka, Kaori Iwata

Anticancer Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformation to small cell lung cancer after first-line afatinib treatment.
Takayuki Shiroyama, Shingo Nasu, Ayako Tanaka, So Takata, Kentaro Masuhiro

Respir Med Case Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Regression of Allergic Bronchopulmonary Mycosis Due to Curvularia lunata.
Shingo Nasu, Shingo Satoh, Kazunori Shimizu, Osamu Matsuno, Hiroshi Morishita

Intern Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma.
Shingo Satoh, Takayuki Shiroyama, Motohiro Tamiya, Shingo Nasu, Ayako Tanaka

Respir Med Case Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case report.
Takayuki Shiroyama, Manabu Hayama, Shingo Satoh, Shingo Nasu, Ayako Tanaka

Respir Med Case Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis